Although Governor Hochul’s long-promised review of New York’s COVID response hasn’t formally started yet, it is already exposing important information about the state’s pandemic preparedness – much of which is unflattering.

On Wednesday, the Hochul administration announced that the study would be conducted by the Olson Group Ltd., an emergency management consulting firm from Alexandria, Va.

Officials said the pending contract calls for the firm to be paid up to $4.3 million, with a report due in one year.

The first revealing bit of evidence is the timing. The hiring came more than two and half years after the state learned how tragically unprepared it was for a major pandemic, and 15 months after a governor resigned rather than face impeachment in part because of how he handled the crisis.

Back in April, Hochul reportedly told her cabinet she wanted a “deep dive” on the state’s response in a matter of weeks, then waited until July to launch the search for outside help. Officials estimated they would award the contract “on or about” Sept. 20, which was six weeks ago. 

Given that COVID killed more than 75,000 New Yorkers – and the next virus could arrive at any time – the state’s leaders might have been expected to show more urgency in studying how to improve their operations.

Next, the $4.3 million price tag seems modest under the circumstances.

That’s less than what former Governor Andrew Cuomo was paid to write his book about the crisis. That’s less than what the Public Service Commission has committed for a “broadband mapping study.” It’s $2.3 million less than what the Assembly paid the law firm that advised its impeachment inquiry.

Given that New York is expecting to receive $30 billion in federal pandemic relief, it could afford to allocate more than 0.015 percent of that amount to understand what went wrong and be better prepared for the next outbreak.

Further revealing details can be found in the state’s answers to questions posed by firms that were thinking of bidding for the study contract.

Firms were curious about how much access they would be given to relevant information such as data, documents and interviews with current and former officials – which is an important consideration given the Cuomo administration’s months-long attempt to hide the true COVID death toll in nursing homes.

The state’s response gave no guarantees:

“The State will work with the vendor to access state data as expeditiously as possible. … Please note, this review does not and will not have the power to compel participation or document production.” (Emphasis added.)

In other words, the Olson Group will not have subpoena power to obtain documents or testimony from the former governor, his top aides or any other uncooperative witnesses – which could be a significant obstacle to getting at the truth.

Would-be bidders also asked whether the state had conducted any other “after-action reviews,” which are considered a standard part of good emergency management.

“We are not aware of any comprehensive [after-action reviews] developed by State Agencies during the previous 2 years on COVID-19 response,” the state replied. “Interim agency reviews, if conducted, can be made available.”

That fact by itself points to a glaring problem: A public health system that doesn’t systematically and routinely learn from its mistakes is doomed to repeat them.

So far, the Hochul administration’s efforts on this front are sending troubling signals. Fully analyzing New York’s response to a catastrophe as big as COVID-19 should be a major, urgent priority for state government – not something to be grudgingly addressed years later by a consultant on a skimpy budget.

About the Author

Bill Hammond

As the Empire Center’s senior fellow for health policy, Bill Hammond tracks fast-moving developments in New York’s massive health care industry, with a focus on how decisions made in Albany and Washington affect the well-being of patients, providers, taxpayers and the state’s economy.

Read more by Bill Hammond

You may also like

One of New York’s Biggest Medicaid Contractors Is Quietly Acquiring a Competitor

As state lawmakers debate the future of Medicaid home care, one of the program's biggest contractors is quietly doubling its market share by buying a competitor. In December, , the Read More

New York’s Home Health Workforce Jumped by 12 Percent in One Year

New York's home health workforce has continued its pattern of extraordinary growth, increasing by 62,000 jobs or 12 percent in a single year, according to newly released data from the U.S. Bureau of Labor Statistics.  Read More

While New York’s Medicaid Budget Soared, Public Health Funding Languished

Four years after a devastating pandemic, the state has made no major investment to repair or improve its public health defenses. While funding for Medicaid over the past four years Read More

A Medicaid Grant Recipient Sponsors a Pro-Hochul Publicity Campaign

While much of the health-care industry is attacking Governor Hochul's Medicaid budget, at least one organization is rallying to her side: Somos Community Care, a politically active medical group in the Bronx that recently r Read More

New Jersey’s Pandemic Report Shines Harsh Light on a New York Scandal

A recently published independent review of New Jersey's pandemic response holds lessons for New York on at least two levels. First, it marked the only serious attempt by any state t Read More

A Politically Active Medical Group Gets $29 Million in ‘Distressed’ Provider Funds

State officials awarded $29 million in 'distressed' provider funding to a politically active medical group in the Bronx, state records confirm. a network of physicians and other he Read More

Albany Lawmakers Push a $4 Billion Tax on Health Insurance

Legislative leaders are proposing an additional $4 billion tax on health insurance plans in the upcoming state budget – but withholding specifics of how it would work. Read More

Loss of Patients and Revenue Foreshadowed Downsizing for SUNY Downstate

The SUNY-owned hospital in Brooklyn facing a newly announced downsizing plan has seen its patient volume and revenue plunge over the past decade, according to a review of its financial reports. Read More